Cancer: looking outside the genome (original) (raw)

• Zhang, L. et al. Gene expression profiles in normal and cancer cells. Science 276, 1268–1272 (1997).
  Article CAS Google Scholar
• Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174 (2000).
  Article CAS Google Scholar
• Moinfar, F. et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res. 60, 2562–2566 (2000).
  CAS Google Scholar
• Bissell, M. J. et al. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 59, S1757–S1763 (1999).
  Google Scholar
• Stoler, D. L. et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA 96, 15121–15126 (1999).
  Article CAS Google Scholar
• Strohman, R. C. The coming Kuhnian revolution in biology. Nature Biotechol. 15, 194–200 (1997).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS Google Scholar
• Nurse, P. Reductionism: The ends of understanding. Nature 387, 657 (1997).
  Article CAS Google Scholar
• Steeg, P. S. & Abrams, J. S. Cancer prognostics: past, present and p27. Nature Med. 3, 152–154 (1997).
  Article CAS Google Scholar
• Szallasi, Z. Bioinformatics: Gene expression patterns and cancer. Nature Biotechol. 16, 1292–1293 (1998).
  Article CAS Google Scholar
• Howard, K. The bioinformatics gold. Sci. Am. July, 58–63 (2000).
  Article Google Scholar
• Huang, S. & Ingber, D.E. The structural and mechanical complexity of cell-growth control. Nature Cell Biol. 1, E131–E138 (1999).
  Article CAS Google Scholar
• Loeb, L. A. Many mutations in cancers. Cancer Surveys 28, 329–342 (1996).
  CAS Google Scholar
• Cahill, D. P., Kinzler, K. W., Vogelstein, B. & Lengauer, C. Genetic instability and darwinian selection in tumours. Trends Cell Biol. 9, M57–M60 (1999).
  Article CAS Google Scholar
• Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS Google Scholar
• Hahnfeldt, P., Panigrahy, D., Folkman, J. & Hlatky, L. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response and post-vascular dormancy. Cancer Res. 59, 4770–4775 (1999).
  CAS Google Scholar
• Perez-Atayde, A. R. et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol. 150, 815–821 (1997).
  CAS Google Scholar
• Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
  Article CAS Google Scholar
• Good, D. J. et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl Acad. Sci. USA 87, 6624–6628 (1990).
  Article CAS Google Scholar
• Browder, T. et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 60, 1878–1886 (2000).
  CAS Google Scholar
• Klement, G. et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Invest. 105, R15–R24 (2000).
  Article CAS Google Scholar
• Folkman, J. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology 139, 441–442 (1998).
  Article CAS Google Scholar
• Feinstein, A. R. The santayana syndrome II: Problems in reasoning and learning about error. Perspect. Biol. Med. 41, 73–85 (1997).
  Article Google Scholar
• Sachs, L. The control of growth and differentiation in normal and leukemic blood cells. The 1989 Alfred P. Sloan Prize of the General Motors Cancer Research Foundation. Cancer 65, 2196–2206 (1990).
  Article CAS Google Scholar
• Folkman, J. in Accomplishments in Cancer Research (eds Wells, S. A. Jr & Sharp, P. A.) 32–44 (J. B. Lippincott Williams and Wilkins, Pennsylvania 1998).
  Google Scholar
• Perletti, G. et al. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res. 60, 1793–1796 (2000).
  CAS Google Scholar
• Boehm, T., Folkman, J., Browder, T. & O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404–407 (1997).
  Article CAS Google Scholar
• Kerbel, R. S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 13, 31–36 (1991).
  Article CAS Google Scholar
• Streit, M. et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl Acad. Sci. USA 96, 14888–14893 (1999).
  Article CAS Google Scholar
• St Croix, B. et al. Genes expressed in human tumor endothelium. Science 289, 1197–1202 (2000).
  Article CAS Google Scholar